MAR001 for hypertriglyceridemia

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 26 Sep 2025: Trial started, NCT07199309
  2. 30 Sep 2025: Trial registered, NCT07199309

The trials

NCT07199309: A Mechanistic Study of MAR001 in Adults With Elevated Triglycerides and Remnant Cholesterol

State
Under way
Phase
Phase 2
People
30 planned
Started
26 Sep 2025
Primary completion
Jul 2026
Arms
MAR001 Dose
Results
None posted
  1. 26 Sep 2025: Trial started
  2. 30 Sep 2025: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.